Comments
762
Joined
May 7, 2009
Badges
Cynthia111
Recent Posts
Renal Cell Carcinoma (Kidney Cancer)
An FDA advisory panel just recommended that the warning for Covidien’s Optimark and GE’s Omnisca—drugs in the family of medications known as gadolinium-based contrast agents (DBCAs)—be updated to restrict their use in patients with severe kidney disease because of the potential for an increased risk of nephrogenic systemic fibrosis (NSF). NSF causes thickening of the skin and organs. GBCAs carry a strong “black box” warning. This site has good information on this issue: http://www.gadolin ium-mri.com/index. html
 (Wednesday Dec 16 | post #15)
Looking for more people on Topix? Browse the Family Album and see who's saying what!|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
